Alexza Pharmaceuticals Inc. — Operating Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/23c6d20c-4f46-415c-882c-916513ffb80d/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2015 | $-40.0M | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-015401 |
| FY 2014 | $-37.5M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-091455 |
| FY 2013 | $1.8M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-114451 |
| FY 2012 | $-28.9M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-126906 |
| FY 2011 | $-355.0M | 2000-12-19 – 2012-03-31 | evidence 0001193125-12-225637 |
| FY 2010 | $-4.7M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-109810 |
| FY 2009 | $-47.7M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-109810 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Alexza Pharmaceuticals Inc. — all facts · Revenue · Net Income